Rmb Capital Management, LLC Pacira Bio Sciences, Inc. Transaction History

Rmb Capital Management, LLC

  • $4.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$50.47 - $66.26 $1.16 Million - $1.52 Million
-22,938 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$51.97 - $63.0 $310,104 - $375,921
-5,967 Reduced 20.64%
22,938 $1.38 Million
Q2 2020

Aug 05, 2020
BUY
$30.8 - $52.47 $890,274 - $1.52 Million
28,905 New
28,905 $1.52 Million

Others Institutions Holding PCRX

# of Institutions
263
Shares Held
50.4M
Call Options Held
429K
Put Options Held
391K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Rmb Capital Management, LLC Portfolio

Follow Rmb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email